Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC13016SafinamideCAS: 133865-89-1纯度: >99.50%
Safinamide 是一种强效、选择性和可逆的单胺氧化酶 B (MAO-B) 抑制剂 (IC50=0.098 μM),优于 MAO-A (IC50=580 μM)。
- GC13031Trifluoperazine 2HClCAS: 440-17-5纯度: >99.00% / >98.00%
An anti-adrenergic and anti-dopaminergic agent
- GC13035Bay 11-7821CAS: 19542-67-7纯度: >99.50% / >95.00%
Bay 11-7821是一种IκBα磷酸化和NF-κB抑制剂,选择性且不可逆地抑制TNF-α诱导的IκB-α磷酸化(IC 50 值约为10μM),并减少NF-κB和粘附分子的表达。Bay 11-7821抑制泛素特异性蛋白酶USP7和USP21,IC 50 分别为0.19、0.96μM。
- GC1304417-DMAG (Alvespimycin) HClCAS: 467214-21-7纯度: >98.00%
17-DMAG (Alvespimycin) HCl是一种有效的Hsp90的抑制剂,其IC 50 值为62nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12991 | EB 47 | 366454-36-6 | >99.50% | |
A PARP1 and TNKS2 inhibitor | ||||
| GC12993 | Vancomycin hydrochloride | 1404-93-9 | >99.50% / >98.00% | |
A glycopeptide antibiotic | ||||
| GC12994 | Rivastigmine Tartrate | 129101-54-8 | >99.00% | |
A cholinesterase inhibitor | ||||
| GC12998 | HIV-1 integrase inhibitor | 544467-07-4 | - | |
HIV-1整合酶抑制剂可用于抗HIV。 | ||||
| GC13000 | Acebutolol HCl | 34381-68-5 | >98.00% / >99.50% | |
A β 1 -AR antagonist | ||||
| GC13003 | AMG-517 | 659730-32-2 | >99.50% | |
A TRPV1 antagonist | ||||
| GC13004 | ML161 | 423735-93-7 | >98.00% | |
Reversible inhibitor of PAR1-mediated platelet activation | ||||
| GC13012 | Motesanib | 453562-69-1 | >99.50% / >98.00% | |
Motesanib (AMG 706) 是一种有效的 ATP 竞争性 VEGFR1/2/3 抑制剂,IC50 分别为 2 nM/3 nM/6 nM,对 Kit 具有相似的活性,对 VEGFR 的选择性比对 VEGFR 的选择性高约 10 倍PDGFR 和 Ret。 | ||||
| GC13015 | LDN-27219 | 312946-37-5 | >99.50% / >98.00% | |
An inhibitor of TG2 | ||||
| GC13016 | Safinamide | 133865-89-1 | >99.50% | |
Safinamide 是一种强效、选择性和可逆的单胺氧化酶 B (MAO-B) 抑制剂 (IC50=0.098 μM),优于 MAO-A (IC50=580 μM)。 | ||||
| GC13018 | IOX2(Glycine) | 931398-72-0 | >99.50% | |
A selective PHD2 inhibitor | ||||
| GC13022 | Esomeprazole Magnesium trihydrate | 217087-09-7 | - | |
An H + /K + -ATPase inhibitor | ||||
| GC13028 | SB 415286 | 264218-23-7 | >99.50% | |
A selective inhibitor of GSK-3 | ||||
| GC13029 | AZD2014 | 1009298-59-2 | >98.50% | |
A potent dual mTORC1/2 inhibitor | ||||
| GC13030 | (R)-(-)-Ibuprofen | 51146-57-7 | >99.50% | |
A less potent enantiomer of ibuprofen | ||||
| GC13031 | Trifluoperazine 2HCl | 440-17-5 | >99.00% / >98.00% | |
An anti-adrenergic and anti-dopaminergic agent | ||||
| GC13035 | Bay 11-7821 | 19542-67-7 | >99.50% / >95.00% | |
Bay 11-7821是一种IκBα磷酸化和NF-κB抑制剂,选择性且不可逆地抑制TNF-α诱导的IκB-α磷酸化(IC 50 值约为10μM),并减少NF-κB和粘附分子的表达。Bay 11-7821抑制泛素特异性蛋白酶USP7和USP21,IC 50 分别为0.19、0.96μM。 | ||||
| GC13040 | TRAM-34 | 289905-88-0 | >99.50% | |
An IKCa1/K Ca 3.1 channel blocker | ||||
| GC13044 | 17-DMAG (Alvespimycin) HCl | 467214-21-7 | >98.00% | |
17-DMAG (Alvespimycin) HCl是一种有效的Hsp90的抑制剂,其IC 50 值为62nM。 | ||||
| GC13045 | Tyrphostin AG 1296 | 146535-11-7 | >99.00% | |
An inhibitor of PDGF receptor kinase | ||||
| GC13053 | Pizotifen | 15574-96-6 | >98.00% | |
A triptan | ||||
| GC13055 | Mocetinostat (MGCD0103, MG0103) | 726169-73-9 | >99.00% | |
An orally available HDAC inhibitor | ||||
| GC13056 | CX-6258 | 1202916-90-2 | >99.50% | |
A pan-Pim kinase inhibitor | ||||
| GC13066 | Y-320 | 288250-47-5 | >99.00% | |
An inhibitor of IL-15-mediated CD4 T cell activation | ||||
